Quadrant Capital Group’s Regenxbio RGNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-734
| Closed | -$5.25K | – | 2321 |
|
|
2025
Q1 | $5.25K | Sell |
734
-1,903
| -72% | -$13.6K | ﹤0.01% | 2345 |
|
|
2024
Q4 | $20.4K | Buy |
2,637
+825
| +46% | +$6.38K | ﹤0.01% | 1887 |
|
|
2024
Q3 | $19K | Buy |
1,812
+1,219
| +206% | +$12.8K | ﹤0.01% | 1914 |
|
|
2024
Q2 | $6.94K | Buy |
593
+545
| +1,135% | +$6.38K | ﹤0.01% | 2216 |
|
|
2024
Q1 | $1.01K | Sell |
48
-342
| -88% | -$7.21K | ﹤0.01% | 2586 |
|
|
2023
Q4 | $7K | Buy |
390
+274
| +236% | +$4.92K | ﹤0.01% | 2190 |
|
|
2023
Q3 | $1.91K | Sell |
116
-134
| -54% | -$2.21K | ﹤0.01% | 2404 |
|
|
2023
Q2 | $5K | Buy |
250
+233
| +1,371% | +$4.66K | ﹤0.01% | 2205 |
|
|
2023
Q1 | $322 | Buy |
+17
| New | +$322 | ﹤0.01% | 2644 |
|
|
2021
Q4 | – | Sell |
-8
| Closed | – | – | 2664 |
|
|
2021
Q3 | $0 | Buy |
+8
| New | – | ﹤0.01% | 2622 |
|
|
2020
Q3 | – | Sell |
-24
| Closed | -$1K | – | 2282 |
|
|
2020
Q2 | $1K | Buy |
+24
| New | +$1K | ﹤0.01% | 2116 |
|
|
2019
Q2 | – | Sell |
-15
| Closed | – | – | 2387 |
|
|
2019
Q1 | $0 | Buy |
+15
| New | – | ﹤0.01% | 2317 |
|